Iovance Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:IOVA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Feb 24	BuyUS$292,800	Iain Dukes	Individual	32,000	US$9.15
20 Feb 24	BuyUS$2,287,500	Merrill McPeak	Individual	250,000	US$9.15
20 Feb 24	BuyUS$45,750,000	Wayne Rothbaum	Individual	5,000,000	US$9.15

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IOVA?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	29,188,859	9.58%
General Public	34,463,389	11.3%
VC/PE Firms	50,614,812	16.6%
Institutions	190,513,730	62.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.1%.

Top Shareholders

Top 25 shareholders own 71.88% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.21%	Wayne Rothbaum	28,067,333	US$240.0m	0%	no data
8.96%	The Vanguard Group, Inc.	27,313,967	US$233.5m	5.25%	no data
8.73%	Perceptive Advisors LLC	26,617,709	US$227.6m	2.64%	4.83%
7.87%	MHR Fund Management LLC	23,997,103	US$205.2m	0%	24.01%
7.05%	BlackRock, Inc.	21,483,668	US$183.7m	1.22%	no data
4.33%	State Street Global Advisors, Inc.	13,201,978	US$112.9m	4.57%	no data
2.94%	T. Rowe Price Group, Inc.	8,964,191	US$76.6m	62%	0.01%
2.8%	Soleus Capital Management, L.P.	8,528,500	US$72.9m	13%	5.93%
2.67%	Hood River Capital Management LLC	8,144,637	US$69.6m	198%	0.97%
1.85%	Geode Capital Management, LLC	5,648,995	US$48.3m	-2.38%	no data
1.58%	Artisan Partners Limited Partnership	4,803,825	US$41.1m	-6.02%	0.03%
1.49%	Long Focus Capital Management LLC	4,532,000	US$38.7m	9.68%	3.18%
1.47%	Balyasny Asset Management L.P.	4,472,576	US$38.2m	-1.5%	0.09%
1.39%	Avoro Capital Advisors LLC	4,240,000	US$36.3m	-63.8%	0.48%
1.32%	Principal Global Investors, LLC	4,033,184	US$34.5m	59%	0.02%
1.25%	Goldman Sachs Group, Investment Banking and Securities Investments	3,805,528	US$32.5m	69.4%	0.01%
1.05%	Macquarie Investment Management Business Trust	3,190,036	US$27.3m	2,510%	0.03%
1%	Palo Alto Investors LP	3,041,685	US$26.0m	43.7%	3.54%
0.84%	UBS Asset Management AG	2,568,971	US$22.0m	-7.91%	no data
0.79%	BioImpact Capital LLC	2,406,714	US$20.6m	1.69%	3.2%
0.74%	Northern Trust Global Investments	2,248,576	US$19.2m	3.77%	no data
0.68%	Dimensional Fund Advisors LP	2,069,592	US$17.7m	-8.65%	no data
0.66%	Bank of America Corporation, Asset Management Arm	2,014,518	US$17.2m	-2.21%	no data
0.63%	Charles Schwab Investment Management, Inc.	1,913,144	US$16.4m	-3.62%	no data
0.58%	Credit Suisse Asset Management (Switzerland) Ltd.	1,781,786	US$15.2m	0%	0.02%